9th Annual Conference Of The British HIV Association [BHIVA]


24 – 26 April 2003, University of Manchester
Institute of Science & Technology (UMIST)
Manchester


Print this article
[TITLE:] CHANGING MORTALITY PATTERNS IN THE HAART ERA

[AUTHOR(S):] J Ashby1, AK Sullivan1, V Kugananthan1, C Watson1, C Mazude1, M Fisher2, M Bower1, BG Gazzard1 and MR Nelson1
1 Chelsea and Westminster Hospital, London, and 2 Royal Sussex County Hospital, Brighton, UK

BHIVA Conf 2003 Apr 24-26;9:O2


AIM: To determine the changing incidence of cause of death with improvements in highly active antiretroviral therapy (HAART).

METHODS: All deaths in three distinct time periods were recorded at two UK centres, period A (pre-HAART): May to November 1994, period B (early HAART): November 1996 to May 1998, period C June 2000 to September 2002.

RESULTS: Deaths per month: 22, 8 and 5; median CD4 count: 20, 35 and 116 cells/µl (P<000.1); viral load below detection: 0%, 8% and 39% (P<0.0001); previous AIDS: 93%, 77% and 44% (P<0001); heterosexual: 3%, 11% and 40% (P<0.0001) for periods A, B, C respectively


n (%) KS Lymphoma PCL Other cancer Liver disease
A 17(13) 3(2) 8(6) 1(<1) 3(2)
B 9(7) 12(9) 7(5) Nil 4(3)
C 3(2) 13(10) 2(2) 14(11) 16(12)
P 0.004 0.03 0.015 <0.001 0.002

n (%) OIs Sepsis Suicide OD ART related Other Not known
A 35(26) 13(10) 1(<1) 0(0) 20(15) 32(24)
B 24(18) 13(10) 5(4) 2(2) 22(17) 35(26)
C 20(15) 24(18) 10(8) 4(3) 11(8) 14(11)
P 0.059 0.056 0.018 0.13 0.11 0.002

ART, antiretroviral therapy; OI, opportunistic infections.

CONCLUSIONS: Mortality has decreased with the advent of HAART. At the time of death individuals have a higher CD4 cell count and are less likely to have had a previous AIDS diagnosis. The spectrum of causation is changing with higher rates due to AIDS-defining cancers, systemic lymphomas, and liver disease and self-harm, while the proportion of deaths from Kaposi's sarcoma (KS) and primary cerebral lymphoma (PCL) has fallen.

PRESENTING AUTHOR: J Ashby

Download Presentation

030424
O24

Copyright © 2003 - British HIV Association (BHIVA) Reproduction of this abstract (other than one copy for personal reference) must be cleared through the BHIVA Organising Secretariat 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD